These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 38684519)
1. The Synthetic Surfactant CHF5633 Restores Lung Function and Lung Architecture in Severe Acute Respiratory Distress Syndrome in Adult Rabbits. Mikolka P; Kosutova P; Kolomaznik M; Nemcova N; Hanusrichterova J; Curstedt T; Johansson J; Calkovska A Lung; 2024 Jun; 202(3):299-315. PubMed ID: 38684519 [TBL] [Abstract][Full Text] [Related]
2. Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome. Mikolka P; Curstedt T; Feinstein R; Larsson A; Grendar M; Rising A; Johansson J Physiol Rep; 2021 Jan; 9(1):e14700. PubMed ID: 33403805 [TBL] [Abstract][Full Text] [Related]
3. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits. Zebialowicz Ahlström J; Massaro F; Mikolka P; Feinstein R; Perchiazzi G; Basabe-Burgos O; Curstedt T; Larsson A; Johansson J; Rising A Respir Res; 2019 Nov; 20(1):245. PubMed ID: 31694668 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of surfactant therapy of ARDS induced by hydrochloric acid aspiration followed by ventilator-induced lung injury - an animal study. Mikolka P; Kosutova P; Kolomaznik M; Mateffy S; Nemcova N; Mokra D; Calkovska A Physiol Res; 2022 Dec; 71(S2):S237-S249. PubMed ID: 36647912 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633. Ricci F; Murgia X; Razzetti R; Pelizzi N; Salomone F Pediatr Res; 2017 Feb; 81(2):369-375. PubMed ID: 27973472 [TBL] [Abstract][Full Text] [Related]
6. Synthetic Surfactant CHF5633 Compared with Poractant Alfa in the Treatment of Neonatal Respiratory Distress Syndrome: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial. Ramanathan R; Biniwale M; Sekar K; Hanna N; Golombek S; Bhatia J; Naylor M; Fabbri L; Varoli G; Santoro D; Del Buono D; Piccinno A; Dammann CE J Pediatr; 2020 Oct; 225():90-96.e1. PubMed ID: 32553868 [TBL] [Abstract][Full Text] [Related]
7. Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes. Glaser K; Fehrholz M; Curstedt T; Kunzmann S; Speer CP PLoS One; 2016; 11(1):e0146898. PubMed ID: 26790130 [TBL] [Abstract][Full Text] [Related]
8. Effects of Natural versus Synthetic Surfactant with SP-B and SP-C Analogs in a Porcine Model of Meconium Aspiration Syndrome. Salvesen B; Curstedt T; Mollnes TE; Saugstad OD Neonatology; 2014; 105(2):128-35. PubMed ID: 24356240 [TBL] [Abstract][Full Text] [Related]
9. Metabolism of a synthetic compared with a natural therapeutic pulmonary surfactant in adult mice. Madsen J; Panchal MH; Mackay RA; Echaide M; Koster G; Aquino G; Pelizzi N; Perez-Gil J; Salomone F; Clark HW; Postle AD J Lipid Res; 2018 Oct; 59(10):1880-1892. PubMed ID: 30108154 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of synthetic surfactant (CHF5633) bolus and/or lavage in meconium-induced lung injury in ventilated newborn rabbits. Xu Y; Guo X; Chen M; Ricci F; Salomone F; Murgia X; Sun B Pediatr Res; 2023 Feb; 93(3):541-550. PubMed ID: 35701606 [TBL] [Abstract][Full Text] [Related]
11. Cerebral and lung effects of a new generation synthetic surfactant with SP-B and SP-C analogs in preterm lambs. Rey-Santano C; Mielgo VE; Murgia X; Gomez-Solaetxe MA; Salomone F; Bianco F; Pelizzi N; Loureiro B; López de Heredia Y Goya J Pediatr Pulmonol; 2017 Jul; 52(7):929-938. PubMed ID: 28221717 [TBL] [Abstract][Full Text] [Related]
12. New surfactant with SP-B and C analogs gives survival benefit after inactivation in preterm lambs. Seehase M; Collins JJ; Kuypers E; Jellema RK; Ophelders DR; Ospina OL; Perez-Gil J; Bianco F; Garzia R; Razzetti R; Kramer BW PLoS One; 2012; 7(10):e47631. PubMed ID: 23091635 [TBL] [Abstract][Full Text] [Related]
13. Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes. Fehrholz M; Glaser K; Seidenspinner S; Ottensmeier B; Curstedt T; Speer CP; Kunzmann S PLoS One; 2016; 11(4):e0153578. PubMed ID: 27077658 [TBL] [Abstract][Full Text] [Related]
14. SP-B and SP-C containing new synthetic surfactant for treatment of extremely immature lamb lung. Sato A; Ikegami M PLoS One; 2012; 7(7):e39392. PubMed ID: 22808033 [TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry imaging as a tool for evaluating the pulmonary distribution of exogenous surfactant in premature lambs. Zecchi R; Franceschi P; Tigli L; Ricci F; Boscaro F; Pioselli B; Mileo V; Murgia X; Bianco F; Salomone F; Schmidt AF; Hillman NH; Kemp MW; Jobe AH Respir Res; 2019 Aug; 20(1):175. PubMed ID: 31382955 [TBL] [Abstract][Full Text] [Related]
16. A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome. Sweet DG; Turner MA; Straňák Z; Plavka R; Clarke P; Stenson BJ; Singer D; Goelz R; Fabbri L; Varoli G; Piccinno A; Santoro D; Speer CP Arch Dis Child Fetal Neonatal Ed; 2017 Nov; 102(6):F497-F503. PubMed ID: 28465315 [TBL] [Abstract][Full Text] [Related]
17. Different effects of surfactant proteins B and C - implications for development of synthetic surfactants. Curstedt T; Johansson J Neonatology; 2010 Jun; 97(4):367-72. PubMed ID: 20551705 [TBL] [Abstract][Full Text] [Related]
18. Synthetic surfactant containing SP-B and SP-C mimics is superior to single-peptide formulations in rabbits with chemical acute lung injury. Walther FJ; Hernández-Juviel JM; Gordon LM; Waring AJ PeerJ; 2014; 2():e393. PubMed ID: 24883253 [TBL] [Abstract][Full Text] [Related]